StonvexLoading…
StonvexStonvexStonvexCore line items from C's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-14 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $23.74B | $85.22B | $65.35B | $43.26B | $21.60B |
Operating Income | Not available | $19.83B | $16.02B | $10.67B | $5.45B |
Net Income | Not available | $14.31B | $11.84B | $8.08B | $4.06B |
EPS (Diluted) | $2.70 | $6.99 | $5.78 | $3.92 | $1.96 |
Total Assets | Not available | $2.66T | $2.64T | $2.62T | $2.57T |
Total Liabilities | Not available | $2.44T | $2.43T | $2.41T | $2.36T |
Cash & Equivalents | Not available | $349.58B | $348.06B | $337.47B | $308.33B |
Free Cash Flow OCF − CapEx | Not available | $-74.15B | $-99.08B | $-98.56B | $-60.23B |
Shares Outstanding | Not available | 1.87B | 1.89B | 1.91B | 1.92B |